Molecular docking indicated that one of our compounds (compound 4, 7-acetyl-3a1-methyl- 4,14-dioxo-1,2,3a,3a1,4,5,5a,6,8a,9b,10,11,11a-tetradecahydro-2,5a epoxy5,6a (methanooxymethano)phenaleno[1′,9′:5,6,7]indeno[1,7a-b]oxiren-2-yl acetate) target EREG and is involved in cervical cancer. This evidence concerns the gene EREG and cervical carcinoma.